Affordable and accessible medicines for the entire world

Trek Therapeutics is a for-profit company, organized as a public benefit corporation.  Its mission is to develop medicines to treat infectious diseases and commercialize them for global populations. The company’s founders have collectively participated in developing seven approved antiviral drugs. Our objective is to profitably develop safe, novel medicines for infectious diseases at affordable and accessible prices.
Latest News: Feb 13 -Trek Therapeutics Announces Oral Presentation of Faldaprevir, TD-6450 and Ribavirin Ph2a Trial Results at the Asian Pacific Association for the Study of the Liver on February 18, 2017 in Shanghai